⌕
MiniMed Group · MMED · Nasdaq
Tenet 60 · Solid
Compare
$17.78−4.66%At closeTenet 60 · Solid
$17.78−0.87 (−4.66%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

MiniMed Group (MMED) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice

28 figures withheld by our checks. Each blank figure names its reason.

Business engineChoppy: revenue compounds ~12.1%/yr (FY24→FY26), net margin −10.7%.
The four lines that matter · FY24–FY26
Revenue ($M)▲14.3%
3,102.0
FY24→FY26CAGR +12.1%/yr
Net income ($M)▼56.3%
−333.0
FY24→FY26CAGR —
Free cash flow ($M)▼692.5%
−420.0
FY24→FY26CAGR —
Diluted EPS▼54.8%
−1.30
FY24→FY26CAGR —
What the income statement says · FY24–FY26
Where every revenue dollar goes · FY26 ($M)3102.0Revenue−1422.0COGS1680.0Gross profit−448.0R&D−1183.0SG&A−190.0Op income−143.0Tax & other−333.0Net income

-11¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
604530150%sector median net margin ~3%FY24FY26

Over this window: gross 58.2% → 54.2%. Net margin -10.7% is below the sector median.

The receipt · income statement · FY24–FY26 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY26FY25FY24YoYCAGR 24→26
Revenue & profitability
Revenue
3,222.03,102.02,715.02,469.0▲14.3%+12.1%
Cost of revenue
1,486.01,422.01,187.01,032.0▲19.8%+17.4%
Gross profit
1,736.01,680.01,528.01,436.0▲9.9%+8.2%
Research & development
438.0448.0436.0437.0▲2.8%+1.3%
Selling, general & admin
1,212.01,183.01,080.01,057.0▲9.5%+5.8%
Total operating expenses
1,908.01,870.01,673.01,505.0▲11.8%+11.5%
Operating incomefeeds ROC rank
−172.0−190.0−146.0−69.0▼30.1%—
Other income, net
0.01.0−1.0−1.0——
Pretax income
−172.0−189.0−147.0−70.0▼28.6%—
Income tax
129.0128.052.038.0▲146.2%+83.5%
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−314.0−333.0−213.0−112.0▼56.3%—
Per share
Diluted EPSbuyback-sensitive
−1.22−1.30−0.84−0.44▼54.8%—
Diluted shares (mn)
281.00256.60252.80252.80▲1.5%+0.7%
Margins
Gross margin34th pct in Healthcare
53.9%54.2%56.3%58.2%▼2.1pp−4.0pp
Operating margin
−5.3%−6.1%−5.4%−2.8%▼0.7pp−3.3pp
Net margin27th pct in Healthcare
−9.7%−10.7%−7.8%−4.5%▼2.9pp−6.2pp
† TTM = trailing four quarters through 2026-07-31.
CSV export is on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-06-29 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was MiniMed Group's revenue last fiscal year?

MiniMed Group reported revenue of $3,102.0M in fiscal 2026, up 14.3% from fiscal 2025.

What was MiniMed Group's net income?

MiniMed Group reported net income of −$333.0M in fiscal 2026, a net margin of −10.7%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.